FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine and describes a chemotherapeutic anti-cancer agent containing a combination of a cholestanol derivative presented by formula 
(1), wherein G represents GlcNAc-Gal- or GlcNAc-, or its inclusion compound with cyclodextrin, and an anti-cancer agent representing one or more types of agents specified in a group consisting of paclitaxel, docetaxel, cyclophosphamide, Pemetrexed, 5-FU, cisplatin and oxaliplatin.
EFFECT: chemotherapeutic anti-cancer agent has weak side effect and excellent efficacy.
7 cl, 9 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHOLESTANOL DERIVATIVE FOR COMBINED ADMINISTRATION | 2009 |
|
RU2519186C2 |
| THERAPEUTIC USE OF THE TLR AGONIST AND COMBINED THERAPY | 2011 |
|
RU2603467C2 |
| PHARMACEUTICAL COMPOSITIONS, COMPOUNDS, METHODS OF SYNTHESIS OF COMPOUNDS | 1995 |
|
RU2168995C2 |
| MODULAR PARTICLES FOR IMMUNOTHERAPY | 2014 |
|
RU2672055C2 |
| COMBINATIONS FOR CANCER TREATMENT INCLUDING ABX196 | 2017 |
|
RU2770432C2 |
| NEW SYNERGETIC EFFECTS | 2009 |
|
RU2471499C2 |
| ABX196 FOR USE IN TREATMENT OF BLADDER CANCER | 2018 |
|
RU2778812C2 |
| BENZOQUINONE E3330 DERIVATIVE IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS FOR TREATING CANCER AND ANGIOGENESIS | 2008 |
|
RU2510270C2 |
| METHODS OF TREATING CANCER | 2013 |
|
RU2657749C2 |
| USE OF ACYLFULVEN ANALOGS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2145849C1 |
